Effects of cirrhosis on kinetics of aztreonam.
Aztreonam was administered as a single, 3-min, 1-g intravenous infusion to 18 subjects, including 6 with biopsy-proven, primary biliary cirrhosis, 6 with biopsy-proven, stable alcoholic cirrhosis, and 6 age- and sex-matched control subjects with normal hepatic functions. Aztreonam was well tolerated...
Shranjeno v:
| izdano v: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1984
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC179951/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6542764/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.4.493 |
| Oznake: |
Brez oznak, prvi označite!
|